Universal Ibogaine

(OTC) IBOGF

Current Price$0.03

Market Cap$8.91M

Since IPO (2022)-54%

5 YearN/A

1 Year+77%

1 Month-8%

Universal Ibogaine Financials at a Glance

Market Cap

$8.91M

Revenue (TTM)

CA$1.54M

Net Income (TTM)

-CA$1.65M

EPS (TTM)

-$0.00

P/E Ratio

-9.27

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

115,755

Open

$0.02

Price

$0.03

Volume

115,755

Open

$0.02

Previous Close

$0.03

Daily Range

$0.02 - $0.03

52-Week Range

$0.00 - $0.35

Estimated Earnings Date

Jan 9, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.03

Volume

115,755

Open

$0.02

Previous Close

$0.03

Daily Range

$0.02 - $0.03

52-Week Range

$0.00 - $0.35

Estimated Earnings Date

Jan 9, 2026

IBOGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Universal Ibogaine

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Nicholas Peter Karos

Website

www.universalibogaine.com

Headquarters

Calgary, AB T2P 4H2, CA

IBOGF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

25%

Net Income Margin

-35%

Return on Equity

-161%

Return on Capital

13%

Return on Assets

-9%

Earnings Yield

-10.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.91M

Shares Outstanding

274.83M

Volume

115.75K

Avg. Volume

1.33M

Financials (TTM)

Gross Profit

CA$1.07M

Operating Income

CA$497.15K

EBITDA

-CA$4.61M

Operating Cash Flow

-CA$4.33M

Capital Expenditure

-CA$95.68K

Free Cash Flow

-CA$4.43M

Cash & ST Invst.

CA$726.05K

Total Debt

CA$1.74M

Universal Ibogaine Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

CA$700.92K

N/A

Gross Profit

CA$700.92K

N/A

Gross Margin

100.00%

N/A

Market Cap

$8.91M

N/A

Market Cap/Employee

$1.27M

N/A

Employees

N/A

Net Income

-CA$66.20K

+92.1%

EBITDA

CA$52.89K

+107.3%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

-CA$2.44M

-53.2%

Accounts Receivable

CA$608.26K

+421.8%

Inventory

CA$0.00

N/A

Long Term Debt

CA$1.72M

+130.2%

Short Term Debt

CA$848.92K

-45.3%

Return on Assets

-9.25%

N/A

Return on Invested Capital

13.35%

N/A

Free Cash Flow

-CA$110.37K

+81.4%

Operating Cash Flow

-CA$110.37K

+75.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GRTXGalera Therapeutics, Inc.

GRTXGalera Therapeutics, Inc.$0.10-5.00%

AAGHAmerica Great Health

AAGHAmerica Great Health$0.00+0.00%

HESGHealth Sciences Group, Inc.

HESGHealth Sciences Group, Inc.$0.00+0.00%

APLIFAppili Therapeutics Inc.

APLIFAppili Therapeutics Inc.$0.01+0.00%

AGNPFAlgernon Pharmaceuticals Inc.

AGNPFAlgernon Pharmaceuticals Inc.$0.34+6.63%

VGLSSB Technology Holdings, Inc.

VGLSSB Technology Holdings, Inc.$0.40+0.00%

ADXSAyala Pharmaceuticals, Inc.

ADXSAyala Pharmaceuticals, Inc.$0.60+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$705.06-0.05%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About IBOGF

What is the current price of Universal Ibogaine?

Universal Ibogaine is trading at $0.03 per share.

What is the 52-week range for Universal Ibogaine?

Over the past 52 weeks, Universal Ibogaine has traded between $0.00 and $0.35.

How much debt does Universal Ibogaine have?

As of the most recent reporting period, Universal Ibogaine reported total debt of CA$1.86M.

How much cash does Universal Ibogaine have on hand?

Universal Ibogaine reported CA$92.48K in cash and cash equivalents in its most recent financial results.

What is Universal Ibogaine’s dividend yield?

Universal Ibogaine does not currently have a dividend yield.

Universal Ibogaine

Universal Ibogaine Financials at a Glance

IBOGF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Universal Ibogaine

IBOGF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Universal Ibogaine Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IBOGF

What is the current price of Universal Ibogaine?

What is the 52-week range for Universal Ibogaine?

How much debt does Universal Ibogaine have?

How much cash does Universal Ibogaine have on hand?

What is Universal Ibogaine’s dividend yield?

Premium Investing Services